✅Chloroquine is a potent inhibitor of SARS coronavirus infection and spread https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/
✅Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study , https://www.preprints.org/manuscript/202005.0057/v1
✅Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France https://www.sciencedirect.com/science/article/pii/S1477893920302179 , http://archive.is/VEdFi
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. https://www.ncbi.nlm.nih.gov/pubmed/15320751
Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
✅Chloroquine Is a Zinc Ionophore https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182877/
Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001837/ , Drug Des Devel Ther. 2018; 12: 1685–1695, Published online 2018 Jun 11. doi: 10.2147/DDDT.S166893
https://pubmed.ncbi.nlm.nih.gov/16115318/
Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread
Here's the new study incoming:
https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
To keep track of the study, look here:
https://clinicaltrials.gov/ct2/show/NCT04358068
Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19
Collaborator: Teva Pharmaceuticals Industries LTD
https://www.ncbi.nlm.nih.gov/pubmed/16115318
and
https://www.ncbi.nlm.nih.gov/pubmed/15351731
Hydroxychloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.
https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/hydroxychloroquine.pdf
Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study
https://www.preprints.org/manuscript/202005.0057/v1
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
https://www.sciencedirect.com/science/article/pii/S1477893920302179
http://archive.is/VEdFi
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.
https://www.ncbi.nlm.nih.gov/pubmed/15320751
Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
HCQ for MS (multiple sclerosis):
Minocycline and Hydroxychloroquine combined
Minocycline and hydroxychloroquine combined are candidate treatments for progressive MS.
https://www.ncbi.nlm.nih.gov/pubmed/28857721
'''Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Hydroxychloroquine 200mg BID for Reducing Progression of Disability in Patients With Primary Progressive Multiple Sclerosis (PPMS)
Hydroxychloroquine in Primary Progressive Multiple Sclerosis'''
https://ichgcp.net/clinical-trials-registry/NCT02913157
Other:
https://clinicaltrials.gov/ct2/show/NCT02913157
Effectiveness of Chloroquine and Hydroxychloroquine in Treating Selected Patients With Sarcoidosis With Neurological Involvement
https://pubmed.ncbi.nlm.nih.gov/9740120/
Use of hydroxychloroquine for treatment of graft-versus-host disease
https://patents.google.com/patent/EP0650727A1/en
HCQ Studies
https://docs.google.com/document/d/1545C_dJWMIAgqeLEsfo2U8Kq5WprDuARXrJl6N1aDjY/edit
https://www.veteranstoday.com/2020/05/24/wuhangate-9-hiv-inserted-in-sars-chimeric-virus-in-2007-pics-thanks-to-australian-eu-commission-funds/
Indomethacin Has a Potent Antiviral Activity Against SARS Coronavirus
https://pubmed.ncbi.nlm.nih.gov/17302372/
https://archive.is/E3DQD
Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies
https://pubmed.ncbi.nlm.nih.gov/32074550/
https://archive.is/YztZs